CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. SEVERANCE AGREEMENT AND...Severance Agreement and General Release • August 6th, 2020 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Severance Agreement and General Release (the “Agreement”) is entered into by and between Timothy Morris (“Employee” or “You”), and Iovance Biotherapeutics, Inc. (the “Company”). The term “Parties” or “Party” used herein shall refer to Employee and the Company as appropriate.
SECOND AMENDMENT TO LEASE AGREEMENTLease Agreement • August 6th, 2020 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This SECOND AMENDMENT TO LEASE AGREEMENT (“Second Amendment”) is dated as of the 30th day of June, 2020 (“Effective Date”), by and between 300 Rouse Boulevard, LLC, a Delaware limited liability company (“Landlord”) and IOVANCE BIOTHERAPEUTICS, INC., a Delaware corporation (“Tenant”).
